Aferna Bio
Vision
Translating cutting-edge biology into commercially relevant crops
Approach
Aferna focuses on utilizing RNA methylation modulation in plants through a class of enzymes to induce significant phenotypic changes, such as increased root biomass and grain size. This innovative approach aims to alter global gene expression, potentially revolutionizing agricultural crop resilience and yield. Aferna is dedicated to translating this groundbreaking science into commercially relevant crops, offering new solutions for enhanced yield and resilience in agriculture.
Aferna Bio is addressing
CEO:
Jon Schmuke
Founders:
Leaps by Bayer
Plaisance Capital
Professor Chuan He, John T. Wilson Distinguished Service Professor at University of Chicago and Howard Hughes Medical Investigator, and winner of the 2023 Wolf Prize in Chemistry
First investment:
January 2022